文献速递临床试验与 GCP

限制性与大量液体复苏策略(REFILL研究)对产科出血失血量及止血参数影响的随机对照试验方案

Restrictive Versus Massive Fluid Resuscitation Strategy (REFILL study), influence on blood loss and hemostatic parameters in obstetric hemorrhage: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-03-06

本研究为随机对照试验方案,拟纳入产后出血500-750 ml且持续出血的产妇,比较常规液体复苏(1.5-2倍失血量)与限制性液体复苏(0.75-1.0倍失血量)对进展为严重产后出血(失血量>1000 ml)的影响,并检测血红蛋白、血细胞比容、血小板及常规凝血参数,部分患者加做血栓弹力图参数。

要点

  • 限制性液体复苏可能减少稀释性凝血病和出血进展。
  • 研究对象为早期轻度产后出血(500-750 ml)且持续出血者。
  • 主要结局为进展为严重产后出血(失血量>1000 ml)。

核心结论

  • 假设大量液体复苏可能因继发性凝血障碍导致出血进展,拟比较两种复苏方案对进展为严重产后出血的影响。

研究设计与样本

  • 随机对照试验方案,纳入产后出血500-750 ml且持续出血的产妇,随机分为常规液体复苏(1.5-2倍失血量)和限制性液体复苏(0.75-1.0倍失血量)两组。

关键数值与推荐

  • 失血量通过称重所有铺巾评估。
  • 在 study 开始时、60分钟后及产后12-18小时采血检测血红蛋白浓度、血细胞比容、血小板浓度及常规凝血参数。
  • 部分患者额外获取血栓弹力图参数。
  • 主要结局指标为进展为严重产后出血(失血量>1000 ml)。

局限性

  • 研究方案阶段,尚未报告结果;非妊娠人群的限制性液体管理数据不能外推至产妇。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postpartum hemorrhage (PPH) is associated with maternal morbidity and mortality and has an increasing incidence in high-resource countries, despite dissemination of guidelines, introduction of skills training, and correction for risk factors. Current guidelines advise the administration, as fluid resuscitation, of almost twice the amount of blood lost. This advice is not evidence-based and could potentially harm patients. METHODS: All women attending the outpatient clinic who are eligible will be informed of the study; oral and written informed consent will be obtained. Where there is more than 500 ml blood loss and ongoing bleeding, patients will be randomized to care as usual, fluid resuscitation with 1.5-2 times the amount of blood loss or fluid resuscitation with 0.75-1.0 times the blood loss. Blood loss will be assessed by weighing all draping. A blood sample, for determining hemoglobin concentration, hematocrit, thrombocyte concentration, and conventional coagulation parameters will be taken at the start of the study, after 60 min, and 12-18 h after delivery. In a subgroup of women, additional thromboelastometric parameters will be obtained. DISCUSSION: Our hypothesis is that massive fluid administration might lead to a progression of bleeding due to secondary coagulation disorders. In non-pregnant individuals with massive blood loss, restrictive fluid management has been shown to prevent a progression to dilution coagulopathy. These data, however, cannot be extrapolated to women in labor. Our objective is to compare both resuscitation protocols in women with early, mild PPH (blood loss 500-750 ml) and ongoing bleeding, taking as primary outcome measure the progression to severe PPH (blood loss > 1000 ml). TRIAL REGISTRATION: Netherlands Trial Register, NTR 3789 . Registered on 11 January 2013.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. de Lange N, Schol P, Lancé M, et al. Restrictive Versus Massive Fluid Resuscitation Strategy (REFILL study), influence on blood loss and hemostatic parameters in obstetric hemorrhage: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29510717. doi:10.1186/s13063-018-2512-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。